MAPT and Alzheimer disease: Guo et al. found that Kai-Xin-San (KXS) ameliorated AD symptoms by reducing tau hyperphosphorylation, AChE levels, TNF-α, IL-1β, and ROS levels, while inhibiting caspase-3 cleavage.